Peru: Medical and Donor Requirements for Surrogacy
The short answer: the official materials do not establish a clearly codified, nationwide donor-screening code for surrogacy that can safely be reduced to one age limit, test panel or anonymity rule. The central legal issue is different. Article 7 of Peru’s General Health Law links genetic and gestational motherhood in one person and requires prior written consent for assisted reproduction. Donor eggs and a separate gestational carrier therefore raise a genuine legal conflict, not merely a clinic-checklist question.
This guide separates binding statutory text, Constitutional Court reasoning and a clinic’s own medical protocol. It covers eggs, sperm, donated embryos and the person who will carry the pregnancy. It does not decide the intended parents’ nationality or family-status eligibility, contract and payment validity, parentage registration, citizenship or travel documents; each is a separate legal question. A clinic offering a procedure is not proof that the procedure or the resulting parentage is legally secure.
1. The binding statutory starting point
Article 7 of Law No. 26842, the General Health Law, recognises access to infertility treatment and assisted reproduction, but states that the genetic mother and the gestational mother must be the same person. It also says that prior written consent of the “biological parents” is required for assisted-reproduction techniques. This is the controlling statutory wording identified in the official legislative text and repeated in the Constitutional Court’s 2025 judgment.
The wording matters most when roles are split. With an egg donor, the woman who provides the egg is not the woman who carries the pregnancy. With gestational surrogacy, the intended mother and the gestational carrier are different people. A literal reading of the same-person condition creates a serious obstacle for both arrangements. Do not treat the absence of a dedicated surrogacy statute as automatic permission to disregard an express condition in the General Health Law.
Article 7 separately prohibits fertilising human ova for purposes other than human procreation and prohibits human cloning. Those express prohibitions should not be confused with a complete donor code: the text does not itself set a donor age, a national infection-testing panel, a genetic-screening list, a maximum number of families per donor, a compensation scale or a uniform anonymity regime.
Prior written consent is an express statutory requirement, but its practical application to a cycle involving third-party gametes is not fully settled by the sources. In the 2025 case discussed below, the Court expressly noted that the consent issue had not been raised and was not decided. Obtain separate, procedure-specific written consent from all relevant participants as a safety measure, but have Peruvian counsel identify who must legally sign and what each form can and cannot achieve.
2. What the Constitutional Court decided in 2025
On 30 June 2025, Peru’s Constitutional Court issued Pleno Sentencia 176/2025 in case Exp. No. 01367-2019-PA/TC. The case record described the intended couple as unable to procreate using their own gametes; the procedure used a donated egg and donated sperm, with a gestational carrier. The Court’s operative result set aside RENIEC decisions that prevented registration of the child as the intended mother’s daughter and ordered correction of the child’s maternal surname.
That outcome matters, but it is not a general licence for every donor or surrogacy arrangement. The operative relief concerned one child and one registry dispute. The lead opinion read Article 7 as restricting egg donation and gestational surrogacy for people whose infertility can be treated or who can use ART without separating genetic and gestational motherhood; it described absolute, irreversible infertility as not expressly regulated. The judges’ separate votes differed on the legal meaning of Article 7 and surrogacy. Do not convert one case-specific outcome into a universal rule.
3. Compare the medical configuration before proceeding
Use this matrix as a screening tool for the legal question to take to counsel, not as a promise that a clinic will accept the cycle or that parentage will be recognised. The result can turn on the precise medical facts, who supplies each gamete, who carries the pregnancy, and how the applicable court reasoning is interpreted.
| Medical configuration | Legal reading and next action |
|---|---|
| Intended mother provides the egg and carries the pregnancy. | This most closely matches Article 7’s same-person wording. It still requires prior written consent, clinical eligibility and separate advice on registration and parentage; the wording alone does not guarantee a successful legal outcome. |
| A donor provides the egg; the intended mother carries the pregnancy. | Genetic and gestational motherhood are split between two women. This conflicts with a literal reading of Article 7 and was not turned into a generally authorised donor route by the 2025 judgment. Obtain a case-specific legal opinion before any treatment. |
| The intended mother provides the egg; another woman carries the pregnancy. | This is gestational surrogacy even though the intended mother is genetically related to the child. Article 7’s same-person condition remains a major issue. Do not assume genetic connection alone resolves legality, enforceability or parentage. |
| A donor provides the egg and a separate woman carries the pregnancy. | Both egg donation and gestational surrogacy are involved. The 2025 case had a related factual configuration, but its registry remedy was case-specific and did not create a general medical or donor code. Legal uncertainty is high. |
| A donor provides sperm; the intended mother provides the egg and carries the pregnancy. | The mother’s genetic and gestational roles may remain with one person, but Article 7’s written-consent language and the donor’s legal status still need analysis. Do not infer a complete sperm-donor framework from the absence of an express ban in Article 7. |
| Both egg and sperm are donated, and a third party carries the pregnancy. | Genetic, intended-parent and gestational roles are all separate. The 2025 judgment involved donated egg and sperm plus a carrier, but did not settle this configuration for all cases or set general donor eligibility, anonymity or consent rules. |
4. What is—and is not—established for donors
Peru has no comprehensive, generally applicable statutory checklist for donor eligibility in its official national rules. Check current requirements before treatment.
Medical screening remains essential, but clinical safety must be distinguished from legal eligibility. Depending on the donor’s role and planned procedure, a specialist may require medical history, examination, infection tests, family-history review, semen analysis or other tests. These may be medically justified or part of clinic policy; they should not be called a nationwide Peruvian legal donor list unless a specific binding instrument is identified.
Donor anonymity and a child’s ability to learn genetic origins are particularly sensitive. The 2025 judgment contains discussion recognising that donor identity, anonymity and the rights of a person conceived through donated gametes raise difficult questions; a separate opinion points out that these issues were not comprehensively resolved. The sources do not establish a complete national rule for donor anonymity, future identity disclosure, medical-record access, storage duration or a donor’s ability to withdraw consent. Ask the clinic exactly what information is collected, preserved and disclosed, to whom and under what legal basis.
5. Clinic medical rules are not nationwide law
A clinic’s acceptance criteria are operational rules for that institution or programme. They may be stricter than a statutory minimum, reflect available services or change when its clinical guidance is updated. Conversely, routine practice or a clinic’s willingness to provide a service does not repeal Article 7 or bind RENIEC or a court. Ask the provider to label each requirement as (1) a law or binding regulation, (2) a court ruling, (3) an official clinical guideline, or (4) its own protocol or medical judgment.
For context, the Instituto Nacional Materno Perinatal (INMP) issued reproductive-medicine guidelines approved in 2021. The IVF pathway described there included criteria such as age up to 40, adequate ovarian reserve, no HIV, syphilis, hepatitis B or C, no indication for egg donation under that pathway, and no pathology threatening the pregnant patient’s life. These are criteria described for that institution’s 2021 IVF pathway, not a national donor law or proof of surrogacy eligibility.
A later INMP resolution dated 7 August 2026 is listed as approving technical procedures for its reproductive-medicine service. Anyone relying on INMP practice should request the current complete protocol and confirm its approval date and scope.
6. Medical screening: questions to put in writing
A medical assessment should establish the infertility diagnosis, planned technique, health of the person carrying the pregnancy, and material risks to that person or the future child. Depending on the case, the clinic may assess reproductive history, uterine anatomy, ovarian reserve, semen parameters, infection risks and relevant genetic history. The exact panel is clinical and case-specific; not every test is automatically required by Peruvian law, and a general IVF protocol does not automatically govern surrogacy or donor selection.
Before a sample is collected or used, request the written donor eligibility and screening protocol. It should identify medical and family-history questions, infection and genetic tests, handling of abnormal or inconclusive results, sample identification and storage, consent documentation, and the response to a health risk discovered later. Ask which requirements are statutory, professional standards or internal policy, and request the source for any claimed legal threshold.
7. Documents to obtain before treatment
Before payment or treatment, request the current protocol for the exact technique; screening schedules for donor and carrier; laboratory and sample-traceability procedures; applicable written consent forms; the donor-identity and future-record-access policy; rules for unused gametes or embryos; and a written explanation of how Article 7 is addressed. Have an independent Peruvian lawyer review the documents rather than relying only on the clinic or intermediary.
8. A safer decision sequence
- Step 1 — Draw a clear role map. Record who provides the egg, who provides the sperm, whether an embryo is donated, and who will carry and give birth to the child. Do not use the general label “donor programme” when the legal question changes between egg donation, sperm donation, embryo donation and gestational surrogacy.
- Step 2 — Obtain a current medical report. It should explain the diagnosis, whether infertility is treatable or absolute and irreversible, why the proposed technique is medically indicated, and the pregnancy risks for the person who will carry the child. The distinction between treatable and absolute, irreversible infertility was material to the lead opinion in the 2025 Constitutional Court case, but should not be treated as a stand-alone eligibility certificate.
- Step 3 — Ask Peruvian counsel for a written analysis of the exact configuration under Article 7 and Exp. 01367-2019-PA/TC. The advice should distinguish the statutory text, the 2025 case’s operative order, the lead opinion and separate votes. It should state which conclusions are settled, which are arguable, and what practical risk remains for the clinic, participants and child.
- Step 4 — Resolve consent and donor-record issues before embryo creation or transfer. Confirm who signs each consent, whether the donor is anonymous or identifiable, what information is retained, whether the child may later request it, and how a consent withdrawal or unused sample is handled. Do not assume a contract can override mandatory law or settle legal parentage by itself.
- Step 5 — Verify the current medical protocol directly with the named clinic. Request its version number, approval date, scope and any updates after 2021. If the provider cites INMP or another public institution’s guidance, obtain the actual document and check that it applies to the same procedure, patient group and donor role.
- Step 6 — Pause if the answer rests only on advertising, a broker’s message or an oral assurance that “everyone does it”. Before treatment, get the legal position and medical protocol in writing, identify the fallback if the clinic or civil registry refuses, and assess parentage and travel consequences separately. A successful pregnancy cannot by itself cure a consent, parentage or registration defect.
If a clinic says the procedure is legal
If a clinic says that donor treatment or surrogacy is “legal in Peru”, ask it to identify the statute, article, binding judgment and factual conditions supporting that statement. Ask whether its conclusion covers the exact combination of egg source, sperm source and gestational carrier. A reference to common practice, a successful prior case or a lawyer’s general opinion is not a substitute for a reasoned assessment of your facts.
Bottom line
The practical starting point is Article 7’s same-person wording and written-consent requirement. The 2025 Constitutional Court case gives a narrow, fact-specific outcome but leaves significant disagreement and regulatory gaps. The official sources do not establish a comprehensive national donor-screening regime. Treat clinic criteria as medical requirements unless a binding legal source is identified, and obtain current medical records and independent Peruvian legal review before proceeding.
Official sources
- Congress of the Republic of Peru, Law No. 26842, General Health Law (official text)
- Constitutional Court of Peru, Pleno Sentencia 176/2025, Exp. No. 01367-2019-PA/TC (official judgment and separate votes)
- Instituto Nacional Materno Perinatal, Reproductive Medicine Clinical and Procedural Guidelines, approved by RD No. 139-2021-DG-INMP/MINSA
- Instituto Nacional Materno Perinatal, RD No.
It is not a medical opinion or an individual legal opinion.
